Key facts
- It has raised $24.4M; the latest was Grant ($600K) in Apr 2025.
- Notable investors include Breakthrough Victoria, ANDHealth, State Government of Victoria, Otsuka Pharmaceutical, Alium Capital Management — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for Atmo Biosciences
- ·The full record, as it builds
Funding rounds
No funding rounds for Atmo Biosciences are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Atmo Biosciences
Developer of a gas-sensing capsule designed to provide real-time gas information for the gut. The company's capsule aids in reporting important data about the human gastrointestinal system by detecting gases in real-time from known locations within the gut, enabling gastroenterologists to do a preferable treatment of gastrointestinal disorders.
- Sector
- Healthcare
- HQ
- Box Hill, Australia
- Employees
- 25
- Website
- atmobiosciences.com/
- Ownership
- Privately Held (backing)
Atmo Biosciences doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Atmo Biosciences shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Atmo Biosciences in its N-PORT filings yet. We sweep new filings monthly.